CTOs on the Move

Record360

www.record360.com

 
Record360 offers industry leading software for digital asset condition documentation, asset condition management, claims management, and analytics for vehicles rentals, fleet management, equipment rentals, truck rentals, property management, towing, movers, dealerships, body shops, auto transportation, car sharing, freight forwarders, and any other industry that benefits from documenting the condition of an asset.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Fastsigns

Fastsigns is a signage, graphics and visual communications partner that provides comprehensive solutions to help customers of all sizes--across all industries--meet their business objectives and increase their business visibility through the use of signs, graphics, printing, promotional products and related marketing services. The almost 700 centers worldwide provide consulting, design, production, project management, delivery and installation. Centers are independently owned and operated. FASTSIGNS operates in the United States (including Puerto Rico), Canada, the United Kingdom, the Caribbean, Mexico, Saudi Arabia, Chile and the UAE. In Australia, centers operate under the name SIGNWAVE®.

Strategic Vision

Strategic Vision is a Atlanta, GA-based company in the Business Services sector.

Red Visuals

Red Visuals is a Edgewood, NY-based company in the Business Services sector.

Family Research Council

Family Research Council is an American fundamentalist Protestant activist group, with an affiliated lobbying organization.

Javara Research

Javara Inc., is a next generation Integrated Research Organization (IRO) designed to engage innovative research partnerships and deploy comprehensive research service offerings to healthcare systems. Together, Javara and their healthcare partners will offer a more aligned, efficient, and effective solution to the challenges of patient inclusion in the ever-increasing complexity and cost of drug development.